InsidersTradesSigma
Explore the full directors' dealings record of 넥스트바이오메디컬, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Market capitalisation: €726.5bn. The latest transaction was filed on 11 March 2026 — Other. Among the most active insiders: 넥스트바이오메디컬. All data is openly available.
FY ended December 2025 · cache
0 of 0 declarations